BV / Quality
Pharmaceutical-grade peptides, lot-traced end-to-end.
Every batch is tested by HPLC, identity-confirmed by mass spectrometry, endotoxin-screened against USP <85>, and released under cGMP-aligned procedures. COAs publish to your portal — not into a sales-rep inbox.
Identity & purity
HPLC + mass spec on every batch.
Reverse-phase HPLC is run on every lot and reported as a percentage with two decimals alongside the mass-spectrometry confirmation. We publish the actual numbers — not a rounded ≥99% claim with no detail behind it.
- HPLC purity
- Reported per lot
- Mass spec
- Identity confirmation
- Endotoxin
- USP <85> per lot
- COA retention
- 7 years
cGMP-aligned production
Manufacturing documentation your inspector expects.
API production runs against documented procedures: lot release checklist, in-process quality controls, USP-aligned identity and purity testing, residual-solvent screens, and microbial bioburden per batch. Manufacturing process documentation and stability data are accessible per SKU on the customer portal.
The paper trail follows the bottle. When an accreditor or pharmacy board asks where the API came from, you can point them at a clean document trail without an email back-and-forth.
Pharmacy documentation
Aligned with pharmacy documentation needs.
Licensed pharmacies face documentation expectations from state boards, FDA, and third-party accreditors. Bioveris API documentation is structured to slot into those records:
- Per-lot COAs with HPLC, mass-spec, endotoxin, residual solvent, and microbial-bioburden results
- Supplier qualification packet with quality agreement template, audit history, and change-notification protocol
- USP-aligned identity testing on every batch — references the specific USP monograph or in-house procedure where USP coverage doesn't exist
- Lot release statement signed by quality-unit personnel; retained for 7 years
Lot traceability
The vial label, the order record, and the COA all carry the same lot number.
When you receive a Bioveris order, the lot stamped on the vial maps back to a batch record in your portal. Pull up any past order and the same lot, COA, and shipping documentation are one click away — for every dose you've ever administered.
That same trail flows into your records, so when a regulator asks how you sourced an ingredient, the answer is on a single screen.
Cold-chain handling
Packed, tendered, and tracked end-to-end.
Vials ship from a temperature-controlled facility in the United States, packaged with phase-change materials sized to the destination ZIP. Tracking numbers post automatically to the order detail page; deliveries to restricted states are blocked at checkout, not discovered in transit.
Restricted-substance allowlist
State-by-state product flags surface at checkout.
State pharmacy and medical board rules around specific peptide compounds change frequently. Bioveris maintains a live allowlist per destination state, blocking any restricted compound at cart-add rather than at delivery. Practitioners operating under a research authorization or other exception can contact compliance for a per-order review.
Ready to read a real COA?
Apply for access. Once your license is verified you can browse the full catalog with the actual lot data behind each SKU.